Back to search

Article

CEP72 Promotes Malignant Progression and Shapes the Tumor Immune Microenvironment in Hepatocellular Carcinoma: Integrated Multi-cohort Bioinformatics and In Vitro Validation

2026-03-20

Abstract excerpt

<title>Abstract</title> <p>Background Immune checkpoint inhibitors (ICIs) benefit only a subset of patients with hepatocellular carcinoma (HCC), and biomarkers linking ICI response with tumor biology remain limited. We investigated CEP72 as an ICI-response–associated gene and evaluated its prognostic, immune, and functional relevance in HCC. Methods Anti–PD-1 response–associated differentially expressed genes (...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
43f2b453-2fed-5070-b4c2-bb09cb36290f
DOI
10.21203/rs.3.rs-9026891/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
CEP72 Promotes Malignant Progression and Shapes the Tumor Immune Microenvironment in Hepatocellular Carcinoma: Integrated Multi-cohort Bioinformatics and In Vitro ValidationDOI 10.21203/rs.3.rs-9026891/v1
Select a neighboring publication to make it the new centre.